193 related articles for article (PubMed ID: 14750783)
1. Synthesis and biological activity of enantiomers of antitumor irofulven.
McMorris TC; Staake MD; Kelner MJ
J Org Chem; 2004 Feb; 69(3):619-23. PubMed ID: 14750783
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of amine analogs of irofulven.
McMorris TC; Chimmani R; Gurram M; Staake MD; Kelner MJ
Bioorg Med Chem Lett; 2007 Dec; 17(24):6770-2. PubMed ID: 17977722
[TBL] [Abstract][Full Text] [Related]
3. Reaction of irofulven with zinc and acid.
McMorris TC; Moon SS; Kelner MJ
J Nat Prod; 2003 Feb; 66(2):310-2. PubMed ID: 12608875
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and analogues.
McMorris TC; Yu J; Lira R; Dawe R; MacDonald JR; Waters SJ; Estes LA; Kelner MJ
J Org Chem; 2001 Sep; 66(18):6158-63. PubMed ID: 11529745
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyurea derivatives of irofulven with improved antitumor efficacy.
Staake MD; Kashinatham A; McMorris TC; Estes LA; Kelner MJ
Bioorg Med Chem Lett; 2016 Apr; 26(7):1836-8. PubMed ID: 26922141
[TBL] [Abstract][Full Text] [Related]
6. Design of highly active analogues of the pyrrolo[1,2-a]benzimidazole antitumor agents.
Craigo WA; LeSueur BW; Skibo EB
J Med Chem; 1999 Aug; 42(17):3324-33. PubMed ID: 10464019
[TBL] [Abstract][Full Text] [Related]
7. Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model.
Kelner MJ; McMorris TC; Rojas RJ; Estes LA; Suthipinijtham P
Cancer Chemother Pharmacol; 2008 Dec; 63(1):19-26. PubMed ID: 18305940
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of alpha-bromoacryloyl lexitropsin conjugates.
Romagnoli R; Baraldi PG; Iaconinoto MA; Carrion MD; Tabrizi MA; Gambari R; Borgatti M; Heilmann J
Eur J Med Chem; 2005 Nov; 40(11):1123-8. PubMed ID: 16006014
[TBL] [Abstract][Full Text] [Related]
9. (+)- and (-)-mutisianthol: first total synthesis, absolute configuration, and antitumor activity.
Bianco GG; Ferraz HM; Costa AM; Costa-Lotufo LV; Pessoa C; de Moraes MO; Schrems MG; Pfaltz A; Silva LF
J Org Chem; 2009 Mar; 74(6):2561-6. PubMed ID: 19231874
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of antitumor activity of arylamides and cyclohexylamides of isomeric 3-chloro-4-(2-chloroethylthio)butanoic- and 4-chloro-3-(2-chloroethylthio)butanoic acids.
Vektariene A; Palaima A; Simkeviciene V
Arzneimittelforschung; 1997 Feb; 47(2):217-22. PubMed ID: 9079243
[TBL] [Abstract][Full Text] [Related]
11. Absolute configuration of chloro-bisabolene sesquiterpene.
Zhu Y; Yu KB; Jia ZJ
Pharmazie; 2004 Jul; 59(7):513-5. PubMed ID: 15296086
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel chloroethylaminoanthraquinones with potent cytotoxic activity against cisplatin-resistant tumor cells.
Pors K; Paniwnyk Z; Ruparelia KC; Teesdale-Spittle PH; Hartley JA; Kelland LR; Patterson LH
J Med Chem; 2004 Mar; 47(7):1856-9. PubMed ID: 15027879
[TBL] [Abstract][Full Text] [Related]
13. The synthesis and anti-proliferative effects of beta-elemene derivatives with mTOR inhibition activity.
Xu L; Tao S; Wang X; Yu Z; Wang M; Chen D; Jing Y; Dong J
Bioorg Med Chem; 2006 Aug; 14(15):5351-6. PubMed ID: 16617020
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of urea, carbamate, and sulfonamide derivatives of acylfulvene.
McMorris TC; Chimmani R; Alisala K; Staake MD; Banda G; Kelner MJ
J Med Chem; 2010 Feb; 53(3):1109-16. PubMed ID: 20067264
[TBL] [Abstract][Full Text] [Related]
15. Towards the synthesis of bisubstrate inhibitors of protein farnesyltransferase: Synthesis and biological evaluation of new farnesylpyrophosphate analogues.
Duez S; Coudray L; Mouray E; Grellier P; Dubois J
Bioorg Med Chem; 2010 Jan; 18(2):543-56. PubMed ID: 20036564
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective synthesis of 15- and 16-substituted isosteviol derivatives and their cytotoxic activities.
Wu Y; Dai GF; Yang JH; Zhang YX; Zhu Y; Tao JC
Bioorg Med Chem Lett; 2009 Mar; 19(6):1818-21. PubMed ID: 19223180
[TBL] [Abstract][Full Text] [Related]
18. Caulerpenyne-colchicine hybrid: synthesis and biological evaluation.
Bourdron J; Commeiras L; Barbier P; Bourgarel-Rey V; Pasquier E; Vanthuyne N; Hubaud JC; Peyrot V; Parrain JL
Bioorg Med Chem; 2006 Aug; 14(16):5540-8. PubMed ID: 16714115
[TBL] [Abstract][Full Text] [Related]
19. Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.
Su TL; Lin YW; Chou TC; Zhang X; Bacherikov VA; Chen CH; Liu LF; Tsai TJ
J Med Chem; 2006 Jun; 49(12):3710-8. PubMed ID: 16759114
[TBL] [Abstract][Full Text] [Related]
20. Potent antitumor bifunctional DNA alkylating agents, synthesis and biological activities of 3a-aza-cyclopenta[a]indenes.
Kakadiya R; Dong H; Lee PC; Kapuriya N; Zhang X; Chou TC; Lee TC; Kapuriya K; Shah A; Su TL
Bioorg Med Chem; 2009 Aug; 17(15):5614-26. PubMed ID: 19576785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
